| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |